27 Feb, 2024
2 mins read

Novartis Arthritis drug fails to help Covid-19 patients

The significant medicine by Novartis named Canakinumab plus standard of care failed to bring about a greater chance of recovery in COVID-19 patients without the need for invasive mechanical ventilation, compared to placebo with standard of care. This was stated by the Swiss Drugmaker on Friday who had hopes that this arthritis drug could be […]